References►
1.
The Ayurvedic Institute.
The Ancient Ayurvedic Writings.
Available at:
http://www.ayurveda.com/. Accessed November 5, 2002.
2.
Roodenrys S, Booth D, Bulzomi S, et al. Chronic effects of Brahmi (
Bacopa monnieri) on human memory.
Neuropsychopharmacology.
2002;27:279-281.
3.
Stough C, Lloyd J, Clarke J, et al. The chronic effects of an extract of
Bacopa monniera
(Brahmi) on cognitive function in healthy human subjects.
Psychopharmacology.
2001;156:481-484.
4.
Nathan PJ, Clarke J, Lloyd J, et al. The acute effects of an extract of
Bacopa monniera
(Brahmi) on cognitive function in healthy normal subjects.
Hum Psychopharmacol.
2001;16:345-351.
5.
Maher BF, Stough C, Shelmerdine A, et al. The acute effects of combined administration of
Ginkgo biloba
and
Bacopa monniera
on cognitive function in humans.
Hum Psychopharmacol.
2002;17:163-164.
6.
Bharani A, Ganguli A, Mathur LK, et al. Efficacy of
Terminalia arjuna
in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing
Terminalia arjuna
with isosorbide mononitrate.
Indian Heart J.
2002;54:170-175.
7.
Gupta R, Singhal S, Goyle A, et al. Antioxidant and hypocholesterolaemic effects of
Terminalia arjuna
tree-bark powder: a randomised placebo-controlled trial.
J Assoc Physicians India.
2001;49:231-235.
8.
Vaidya AB, Antarkar DS, Doshi JC, et al.
Picrorhiza kurroa
(Kutaki) Royle ex Benth as a hepatoprotective agent—experimental & clinical studies.
J Postgrad Med.
1996;42:105-108.
9.
Sharma S, Bhargava R, Singhal K. Double blind study to assess the efficacy of in acute rhinitis.
Indian J Pharmacol.
1990;22:103-105.
10.
Shahani S, Dhadkar VN, Maroli S. The antihistaminic activity of Septilin and its role in topical eosinophillia
Indian J Pharmacol.
1993;25:114.
11.
Rao CS, Raju C, Gopumadhavan S, et al. Immunotherapeutic modification by an ayurvedic formulation Septilin.
Indian J Exp Biol.
1994;32:553-558.
12.
Koti ST. Evaluation of Septilin in persistent low-grade infections in school-children: a placebo-controlled study.
Probe.
1992;31:325.
13.
Agrawal A, Dubey M, Dubey G. Effects of Mentat on memory span, attention, galvanic skin resistance (GSR) and muscle action potential (EMG) among normal adults.
Pharmacopsychoecologia.
1990;3:39-42.
14.
Dixit S, Agrawal U, Dubey G. Executive fatigue and its management with Mentat.
Pharmacopsychoecologia.
1993;6:7-9.
15.
Evaluation of BR-16 A (Mentat) in cognitive and behavioural dysfunction of mentally retarded children—a placebo-controlled study.
Indian J Pediatr.
1993;60:423-428.
16.
Quadri AA. Mentat (BR-16A) in mentally retarded children with behavioral problems.
Curr Med Pract.
1993;37:121.
17.
Patel RB, Pereira L. Experience with Mentat (BR-16A).
Probe.
1991;30:271.
18.
D’souza, Chavda KB. Mentat (BR-16A) in hyperactivity and attention deficiency disorders—a double-blind, placebo-controlled study.
Probe.
1991;30:227.
19.
Dayal RS, Kaira A, Misra MN. Role of Mentat (BR-16A) in behavioural disorders following postnatal organic lesions of the central nervous system (CNS).
Probe.
1991;30:305.
20.
Sharma K, Kushwaha H, Sharma, S. A placebo-controlled trial on the efficacy of Mentat in managing depressive disorders.
Probe.
1993;33:26-31.
21.
Banerjee S, Mukherjee A. Mentat (BR-16A)—a herbomineral preparation, as an adjuvant to conventionally used antiepileptic therapy reducing memory loss caused by electroconvulsive therapy (ECT).
The Ind Pract.
1994;47:929.
22.
Shah LP, Patkar SA. Role of Mentat (BR-16A) in ECT-induced amnesia: a preliminary study.
The Ind Pract.
1993;3:225.
23.
Ratna M, Abhijeet B, Mrudula A. Seizure control and pattern of behaviour in children with simple febrile convulsions—effect of Mentat syrup.
The Ind Pract.
2001;54:729.
24.
Agrawal A, Dixit, S, Dubey G. Role of Mentat in the management of post-stroke aphasia.
The Ind Pract.
1994;47:211-214.
25.
Sharma AK, Agrawal A, Agrawal U, et al
.
Influence of Mentat (BR-16A) on memory and mental fatigue in cases of anxiety neurosis and depression.
Ind J Cancer Res.
1990;3:27.
26.
Mani A, Indirabai K, Ramesh S, et al. Double-blind trial of Mentat (BR-16A) in enuresis.
The Antiseptic.
1993;90:538.
27.
Das DG. A double-blind clinical trial of kamalahar, an indigenous compound preparation, in acute viral hepatitis.
Indian J Gastroenterol.
1993;12:126-128.
28.
Saxena S, Garg AK, Jain A. Liv.52 in infective hepatitis. A study of Liv.52 therapy in infective hepatitis in children.
Current Medical Practice.
1980;5:194.
29.
Sama SK, Krishnamurthy L, Ramachandran K, et al. Efficacy of Liv.52 in acute viral hepatitis. A double-blind study.
Indian J Med Res.
1976;5:738.
30.
Mendal JN, Roy BK. Studies with Liv.52 in the treatment of infective hepatitis, chronic active hepatitis and cirrhosis of the liver.
Probe.
1983;22:217.
31.
Banerjee P, Mitra SR, Nandi M, et al. A preliminary report on clinical trial of Rumalaya on frozen shoulders.
Indian Med J.
1976;70:29.
32.
Paranjpe P, Patki P, Patwardhan B. Ayurvedic treatment of obesity: a randomised double-blind, placebo-controlled clinical trial.
J Ethnopharmacol.
1990;29:1-11.
33.
Kulkarni RR, Patki PS, Jog VP, et al. Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study.
J Ethnopharmacol.
1991;33:91-95.
34.
Mohan V. Evaluation of Diabecon (D-400) as an antidiabetic agent—a double blind placebo controlled trial in NIDDM patients with secondary failure to oral drugs.
Indian Journal of Clinical Practice.
1998;8:9,18.
35.
Lalla JK, Nandedkar SY, Paranjape MH, et al. Clinical trials of ayurvedic formulations in the treatment of acne vulgaris.
J Ethnopharmacol.
2001;78:99-102.
36. Chatterjee S. Advances in the pharmacology of anti-infective therapy. Paper presented at: International Symposium, Astra Zeneca Research Foundation and International Society of Anti-Infective Pharmacology; 2000; Bangalore, India.
37. Dahanukar SA, Ogale SB. Paper under publication. Mumbai, India: Seth GS Medical College and KEM Hospital; 1999.
38. Biswas NR, et al. Paper presented at: Centre for Opthalmic Sciences, All India Institute of Medical Sciences; New Delhi, India; 1996.
39.
Chopra A, Lavin P, Patwardhan B, et al. Randomized double blind trial of an ayurvedic plant derived formulation for treatment of rheumatoid arthritis.
J Rheumatol.
2000;27:1365-1372.
40.
Vijayasarathy V, Sharma LK, Prakash ATM. Indigenous drug therapy for haemorrhoids.
The Med & Surg.
1981;1-2,22.
41.
Vaishali N, Veena S, Dhar H, et al. Double-blind comparative trial of Abana and methyldopa for monotherapy of hypertension in Indian patients.
Japanese Heart Journal.
1990;31:193.
42.
Antani J, Kulkarni R, Antani N. Effect of Abana on ventricular function in ischaemic heart disease.
Japanese Heart Journal.
1990;31:829-835.
43.
Damie VB, Gore AG. A controlled trial of Geriforte in post-menopausal depression.
The Ind Pract.
1982;35:21.
44.
Patnaik BC, Misra SC. The evaluation of Geriforte as a general metabolic tonic in aged persons.
The Med & Sur.
1983;6:27.
45.
Ganeriwal SK, Reddy BV, Baji PS, et al. The effect of Geriforte on blood chemistry.
The Ind Pract.
1981;34:559.
46.
Kulsreshtha JK, Handa RK. A clinical study on Geriforte.
The Ind. Pract.
1978; 5:247.
47.
Gulbranson SH, Hud JA, Hansen RC. Argyria following the use of dietary supplements containing colloidal silver protein.
Cutis.
2000;66:373-374,376.
48.
de Silva HA, Saparamadu PA, Thabrew MI, et al. Liv.52 in alcoholic liver disease: a prospective, controlled trial.
J Ethnopharmacol.
2003;84:47-50.
49.
Tait PA, Vors A, James S, et al. Severe congenital lead poisoning in a preterm infant due to a herbal remedy.
Med J Aust.
2002;177:193-195.
50.
Falkenbach A, Oberguggenberger R. Ayurveda in ankylosing spondylitis and low back pain.
Ann Rheum Dis.
2003;62:276-7.
51.
Prlic HM, Lehman AJ, Cibere J, et al. Agreement among Ayurvedic practitioners in the identification and treatment of three cases of inflammatory arthritis.
Clin Exp Rheumatol.
2003;21:747-52.
52.
Nathan PJ, Tanner S, Lloyd J, et al. Effects of a combined extract of
Ginkgo biloba
and
Bacopa monniera
on cognitive function in healthy humans.
Hum Psychopharmacol.
2004;19:91-96.
53.
Hsia SH, Bazargan M, Davidson MB, et al. Effect of Pancreas Tonic (an Ayurvedic herbal supplement) in type 2 diabetes mellitus.
Metabolism.
2004;53:1166-73.
54.
Saper RB, Kales SN, Paquin J, et al. Heavy metal content of Ayurvedic herbal medicine products.
JAMA.
2004;292:2868-2873.
55.
Lala LG, D'Mello PM, Naik SR, et al. Pharmacokinetic and pharmacodynamic studies on interaction of "Trikatu" with diclofenac sodium.
J Ethnopharmacol.
2004;91:277-80.
56.
Huseini HF, Alavian SM, Heshmat R, et al. The efficacy of Liv-52 on liver cirrhotic patients: a randomized, double-blind, placebo-controlled first approach.
Phytomedicine.
2005;12:619-24.
57.
Murali PM, Rajasekaran S, Krishnarajasekar OR, et al. Plant-based formulation for bronchial asthma: a controlled clinical trial to compare its efficacy with oral salbutamol and theophylline.
Respiration.
2005 Nov 22. [Epub ahead of print].
58.
van Schalkwyk J, Davidson J, Palmer B, Hope V. Ayurvedic medicine:
patients in peril from plumbism.
NZMJ.
2006;119. New Zealand Medical Association website. Available at:
http://www.nzma.org.nz/journal/abstract.php?id=1958.
59.
Elder C, Aickin M, Bauer V, et al. Randomized trial of a whole-system ayurvedic protocol for type 2 diabetes.
Altern Ther Health Med.
2006;12:24-30.
60.
Chopra A, Lavin P, Patwardhan B, et al. A 32-week randomized, placebo-controlled clinical evaluation of RA-11, an ayurvedic drug, on osteoarthritis of the knees.
J Clin Rheumatol.
2006;10:236-245.
61.
Rangineni V, Sharada D, Saxena S. Diuretic, hypotensive, and hypocholesterolemic effects of eclipta alba in mild hypertensive subjects: a pilot study.
J Med Food.
2007;10:143-148.
62.
Prasad KP, Tharangani PG, Samaranayake CN. Recurrent relapses of depression in a patient established on sertraline after taking herbal medicinal mixtures—a herb-drug interaction?
J Psychopharmacol.
2008 May 30.
63.
Saper RB, Phillips RS, Sehgal A, et al. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet.
JAMA.
2008;300:915-923.
64.
Agarwal V, Abhijnhan A, Raviraj P.
Ayurvedic medicine for schizophrenia.
Cochrane Database Syst Rev.
2007;(4):CD006867.
65.
Krishnamurthy MN, Telles S. Assessing depression following two ancient Indian interventions: effects of yoga and ayurveda on older adults in a residential home.
J Gerontol Nurs.
2007;33(2):17-23.
66.
Sridharan K, Mohan R, Ramaratnam S, Panneerselvam D. Ayurvedic treatments for diabetes mellitus.
Cochrane Database Syst Rev.
2011;12:CD008288.